Clinical Resolution Laboratory Recalls Topical Anesthetic Due to Failure to Meet Child Resistant Closure Requirement; Risk of Poisoning
Name of Product:
Numb 100 Topical Anesthetic Cream
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
February 28, 2019
This recall involves Numb 100 Topical Anesthetic Cream. The recalled cream is in a 1.35 fluid ounce white jar with a rounded cap. Numb 100 Topical Anesthetic Cream and a blue cross are printed on the jar’s front panel.
Consumers should immediately place the recalled topical anesthetic out of reach of children and contact Clinical Resolution Laboratory for a full refund, a free replacement cream, or free replacement child-resistant cap.
Clinical Resolution Laboratory, Inc. of Brea, Calif.
Laser Jet, Inc. of Brooklyn, N.Y.
About the U.S. CPSC
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risks of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product incidents cost the nation more than $1 trillion annually. CPSC’s work to ensure the safety of consumer products has contributed to a decline in the rate of deaths and injuries associated with consumer products over the past 40 years. Federal law bars any person from selling products subject to a publicly announced voluntary recall by a manufacturer or a mandatory recall ordered by the Commission.
For lifesaving information: